[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335115-105":59,"doc-detail-335115-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","the-expression-and-clinical-significance-of-arhgap25-in-osteosarcoma-based-on-bioinformatics-analysis","The expression and clinical significance of ARHGAP25 in osteosarcoma based on bioinformatics analysis","","ARHGAP25, a Rho-GTPase negative regulator involved in actin remodeling, cell polarity, and migration, is reduced in many solid tumors, but its role in osteosarcoma was unclear. qPCR and WB validated ARHGAP25 expression changes using pan-cancer screening. Bioinformatics identified 300 TARGET osteosarcoma genes correlated with ARHGAP25, and nomograms and calibration charts were built. Functional tests showed ARHGAP25 overexpression triggered apoptosis, suppressed proliferation, and methylation changes were linked to its decreased expression, with additional immune pathway associations and prognostic value.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-expression-and-clinical-significance-of-arhgap25-in-osteosarcoma-based-on-bioinformatics-analysis/335115/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-expression-and-clinical-significance-of-arhgap25-in-osteosarcoma-based-on-bioinformatics-analysis/335115.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is ARHGAP25 and why is it relevant to osteosarcoma?","Question",{"text":113,"@type":114},"ARHGAP25 encodes a negative regulator of Rho-GTPase, influencing actin remodeling, cell polarity, and migration. Its reduced expression in solid tumors suggested potential involvement in osteosarcoma biology and clinical outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was ARHGAP25 expression evaluated in the study?",{"text":118,"@type":114},"The study used qPCR and Western blot to confirm ARHGAP25 expression in osteosarcoma after initial expression analysis in pan-cancer, and it also leveraged GEO and pan-cancer datasets for mRNA/protein comparisons.",{"name":120,"@type":111,"acceptedAnswer":121},"What functional impact did ARHGAP25 overexpression have on osteosarcoma cells?",{"text":122,"@type":114},"ARHGAP25 overexpression induced apoptosis and inhibited osteosarcoma cell proliferation in vitro. It also showed relevance to epithelial–mesenchymal transition-related processes discussed in the background.",{"name":124,"@type":111,"acceptedAnswer":125},"How is ARHGAP25 downregulation connected to methylation and prognosis?",{"text":126,"@type":114},"The decrease in ARHGAP25 expression in osteosarcoma was related to DNA methylation, and low ARHGAP25 levels were associated with poor patient outcomes, including overall survival and metastasis.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},335115,1790535082,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":4},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe expression and clinical significance ofARHGAP25 in osteosarcoma based on bioinformatics analysis  \nXiaoqian Liu1,3, Siyuan Zhang1,3, Dong Wang1,3, Kaili Lv2, Yonggui Wang1* & Lei Peng1*  \nARHGAP25, a member oftheARHGAP family, encodes a negative regulator of Rho-GTPase that is important for actin remodeling, cell polarity, and cell migration. ARHGAP25 is down-regulated in a variety of solid tumors and promotes cancer cell growth, migration, and invasion. However, nothing is understood about ARHGAP25’s biological function in osteosarcoma. This work used qPCR and WB to confirm the expression ofARHGAP25 in osteosarcoma following the initial analysis of its expression in pan-cancer. ForGO and KEGG analysis, we have chosen 300 genes from the TARGET osteosarcoma data that had the strongest positive correlation with ARHGAP25, and we created nomogram and calibration charts. We simultaneously overexpressed ARHGAP25 in osteosarcoma cells to examine its impact on apoptosis and proliferation. By using MSP, we determined their methylation status in osteosarcoma cells and normal bone cells. We observed that ARHGAP25 was significantly downregulated in a range of malignancies, including osteosarcoma, and was associated with poor patient outcomes. The decrease ofARHGAP25 expression in osteosarcoma is related to DNA methylation. Overexpression ofARHGAP25 induced apoptosis and inhibited the proliferation of osteosarcoma cells in vitro. In addition, ARHGAP25 is also associated with immune-related pathways in osteosarcoma. These findings suggest that ARHGAP25 is a valuable prognostic biomarker in osteosarcoma patients.  \nKeywords Osteosarcoma, ARHGAP25, Methylation, Biomarker  \nAdolescence is the peak period of risk for osteosarcoma, the most common cancer of the bones with a high potential for local invasion and metastasis. In most osteosarcoma cases, pulmonary metastasis is the most common cause of death, but its origin is not fully understood. Patients with unresectable or recurrent osteosarcoma have a poor prognosis and require combination treatment in addition to thorough surgical excision of all detected lesions. Thus, a greater understanding of osteosarcoma metastasis is crucial for finding more reliable and effective biomarkers to aid in early diagnosis, survival evaluation, and treatment.  \nARHGAP25 (Rho GTPase Activating Protein 25) is a negative regulator of the Rho family of GTPases 1. Recent research has demonstrated that ARHGAP25 boosted the proliferation, migration, and invasion of cancer cells in solid tumors such as colorectal cancer (CRC), pancreatic adenocarcinoma (PAAD), and lung cancer2–6. The p.G218R unique heterozygous missense mutation in ARHGAP25 alters the function of bone cells, most likely leading to poor bone resorption and turnover and, as a result, increased skeletal fragility and fracture risk7. In vitro, the overexpression of ARHGAP25 prevented osteosarcoma cells from growing, migrating, and undergoing epithelial–mesenchymal transition (EMT)8. However, little is known about how ARHGAP25 works biologically in osteosarcoma. As a result, research into the function ofARHGAP25 will help us comprehend the molecular processes underlying the advancement of osteosarcoma.  \nTo methodically convey our findings, we created a flow chart (Fig. 1). According to our findings, in numerous kinds of cancers, including osteosarcoma, ARHGAP25 is dramatically downregulated and is linked to a bad outcome for patients. There was a link between low ARHGAP25 expression and worse total survival and metastasis. Additionally, a reduction in the expression ofARHGAP25 in osteosarcoma is linked to CpG methylation. It was  \n1First Affiliated Hospital Trauma Center, Hainan Medical University, Haikou 570100, China. 2Second Affiliated Hospital Gynecology Department, Hainan Medical University, Haikou 570100, China. 3These authors contributed equally: Xiaoqian Liu, Siyu","cbCairlK2RWCFCV3","https://ap.wps.com/l/cbCairlK2RWCFCV3","pdf",6953199,11,"English","# ARHGAP25 expression in pan-cancer\n## Expression patterns across TCGA and GTEx\n## Validation in GEO osteosarcoma datasets\n# ARHGAP25 expression and patient prognosis\n## Association with overall survival and metastasis\n# DNA methylation mechanism\n## CpG methylation link to ARHGAP25 downregulation\n# Functional effects in osteosarcoma cells\n## Overexpression effects on apoptosis and proliferation","[{\"question\":\"What is ARHGAP25 and why is it relevant to osteosarcoma?\",\"answer\":\"ARHGAP25 encodes a negative regulator of Rho-GTPase, influencing actin remodeling, cell polarity, and migration. Its reduced expression in solid tumors suggested potential involvement in osteosarcoma biology and clinical outcomes.\"},{\"question\":\"How was ARHGAP25 expression evaluated in the study?\",\"answer\":\"The study used qPCR and Western blot to confirm ARHGAP25 expression in osteosarcoma after initial expression analysis in pan-cancer, and it also leveraged GEO and pan-cancer datasets for mRNA/protein comparisons.\"},{\"question\":\"What functional impact did ARHGAP25 overexpression have on osteosarcoma cells?\",\"answer\":\"ARHGAP25 overexpression induced apoptosis and inhibited osteosarcoma cell proliferation in vitro. It also showed relevance to epithelial–mesenchymal transition-related processes discussed in the background.\"},{\"question\":\"How is ARHGAP25 downregulation connected to methylation and prognosis?\",\"answer\":\"The decrease in ARHGAP25 expression in osteosarcoma was related to DNA methylation, and low ARHGAP25 levels were associated with poor patient outcomes, including overall survival and metastasis.\"}]","The expression and clinical significance of ARHGAP25 in osteosarcoma based on bioinformatics analysis | PDF",1790009712,28]